Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Nuclide Therapeutics Logo
Nuclide Therapeutics Growth Score
52
CB Rank
44123
Heat Score
61
Nuclide Therapeutics provides radiopharmaceutical medicines that combine nuclear medicine and biotechnology.
Founded
obfuscation
PrivateSeed London, England, United Kingdom1-10 nuclidetx.com/
Health Care
Pharmaceutical
Therapeutics
Overview

Nuclide Therapeutics
Total Funding
obfuscation
Growth Score
52
Heat Score
61

Total Funding
obfuscation
obfuscation
Seed raised
obfuscation
Growth Score52
-11 pts
in past quarter
Heat Score 61
5 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
+2 more milestones
See more interactive data and historical milestones on desktop for the best experience

About Nuclide Therapeutics

CB Rank
44123
Nuclide Therapeutics provides radiopharmaceutical medicines that combine nuclear medicine and biotechnology.
Founded
obfuscation
PrivateSeed London, England, United Kingdom1-10 nuclidetx.com/
Health Care
Pharmaceutical
Therapeutics

Funding Rounds

Seed
OBF
in
obfuscation
Grant
OBF
in
obfuscation

Key People

Details

Legal Name Nuclide Therapeutics Ltd
Operating Status Active
Company Type For Profit
Founders  Muhammet Tanc, Richard Edwards, Sofia Santos, Tim Witney
About the Company
Nuclide Therapeutics provides radiopharmaceutical medicines that combine nuclear medicine and biotechnology to target novel cancer biomarkers.
Contact Email info@nuclidetherapeutics.com.
Predictions & Insights

Growth Insight

See this Growth Insight
Nuclide Therapeutics is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Runway Speculation

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Nuclide Therapeutics Logo
Seed Round - Nuclide Therapeutics
1
obfuscation
Marathon BeteiligungsSeed
obfuscation
Seed Round - Nuclide Therapeutics Logo
Seed Round - Nuclide Therapeutics
1
obfuscation
Marathon BeteiligungsSeed
obfuscation
Seed Round - Nuclide Therapeutics Logo
Seed Round - Nuclide Therapeutics
1
obfuscation
Marathon BeteiligungsSeed
obfuscation
Seed Round - Nuclide Therapeutics Logo
Seed Round - Nuclide Therapeutics
1
obfuscation
Marathon BeteiligungsSeed
obfuscation
Seed Round - Nuclide Therapeutics Logo
Seed Round - Nuclide Therapeutics
1
obfuscation
Marathon BeteiligungsSeed

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Nuclide Therapeutics Logo
Seed Round - Nuclide Therapeutics
1
obfuscation
Marathon BeteiligungsSeed
obfuscation
Seed Round - Nuclide Therapeutics Logo
Seed Round - Nuclide Therapeutics
1
obfuscation
Marathon BeteiligungsSeed
obfuscation
Seed Round - Nuclide Therapeutics Logo
Seed Round - Nuclide Therapeutics
1
obfuscation
Marathon BeteiligungsSeed
obfuscation
Seed Round - Nuclide Therapeutics Logo
Seed Round - Nuclide Therapeutics
1
obfuscation
Marathon BeteiligungsSeed
obfuscation
Seed Round - Nuclide Therapeutics Logo
Seed Round - Nuclide Therapeutics
1
obfuscation
Marathon BeteiligungsSeed

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 3

Employee Profiles

News

News and Press

News•Apr 2, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Sep 30, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

199

IT Spend

$70.8KThis year, Nuclide Therapeutics is projected to spend $70.8K on IT, according to Aberdeen.

Active Website Tech Count

2Nuclide Therapeutics is actively using 2 technologies for its website, according to BuiltWith. These include CommonCrawl Top 50m.
Sub-Organizations
Frequently Asked Questions

Where is Nuclide Therapeutics's headquarters? Nuclide Therapeutics is located in London, England, United Kingdom.Who invested in Nuclide Therapeutics? Nuclide Therapeutics has 2 investors including Marathon Beteiligungs and  Wellcome Trust.When was the last funding round for Nuclide Therapeutics? Nuclide Therapeutics closed its last funding round on
obfuscation
from a Seed round.Who are Nuclide Therapeutics's competitors? Alternatives and possible competitors to Nuclide Therapeutics may include RayzeBio, Telix Pharmaceuticals, and  Isotopen Technologien München.How much funding has Nuclide Therapeutics raised to date? Nuclide Therapeutics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(3e39328 1)
|